Strikingly, the odds of developing AD are approximately 14 times higher in individuals with two ε4 alleles and ten times higher than in individuals with ε3ε4; thus, APOE-ε4 is considered an important biomarker in predicting whether or not an individual will go on to develop late-onset AD [3, 4]. Here, APOE is linked to Alzheimer disease.